Medical surveillance for antineoplastic-drug handlers

M. A. McDiarmid

Research output: Contribution to journalArticle

Abstract

Elements of a medical surveillance program are described, with emphasis on a program for antineoplastic-drug handlers in a hospital setting. There are four data-gathering elements in any medical surveillance program: the history (medical and occupational), the physical examination, laboratory studies, and biological monitoring. Of these, the most useful and cost-effective is the history. The physical examination and laboratory tests should focus on the target organs of the hazardous agent in question. When results of biological monitoring are available for an unexposed control population, results for a group of exposed workers may be interpreted as greater than, similar to, or less than what was expected; thus, groups of unacceptably exposed workers may be identified. For antineoplastic-drug handling, the most important controls are use of a biological-safety cabinet and a worker education program. Estimating the average number of hours of drug handling per shift may serve as a surrogate measure of the potential exposure dose. Health-care professionals examining and testing workers who handle antineoplastic agents should give special emphasis to the skin and the hematopoietic, hepatic, renal, and urinary systems. Because of problems with assay sensitivity, cost, and interpretation of results, biological monitoring is not considered necessary in every medical surveillance program for antineoplastic drug handlers. The Occupational Safety and Health Administration currently recommends that a permanent registry be maintained of all employees who routinely handle antineoplastic agents. Because of their opportunity for exposure to potentially hazardous drugs, pharmacy professionals should take a leading role in establishing surveillance programs that complement existing drug-handling practices and worker education programs.

Original languageEnglish (US)
Pages (from-to)1061-1066
Number of pages6
JournalAmerican Journal of Hospital Pharmacy
Volume47
Issue number5
StatePublished - 1990

Fingerprint

Antineoplastic Agents
Environmental Monitoring
Physical Examination
History
Pharmaceutical Preparations
United States Occupational Safety and Health Administration
Education
Costs and Cost Analysis
Registries
Delivery of Health Care
Kidney
Safety
Skin
Liver
Population

Keywords

  • administration
  • antineoplastic agents
  • control
  • documentation
  • dosage
  • education
  • guidelines
  • laminar airflow
  • occupational safety and health administration
  • personnel
  • safety
  • toxicity, environmental

ASJC Scopus subject areas

  • Leadership and Management
  • Pharmaceutical Science

Cite this

Medical surveillance for antineoplastic-drug handlers. / McDiarmid, M. A.

In: American Journal of Hospital Pharmacy, Vol. 47, No. 5, 1990, p. 1061-1066.

Research output: Contribution to journalArticle

McDiarmid, M. A. / Medical surveillance for antineoplastic-drug handlers. In: American Journal of Hospital Pharmacy. 1990 ; Vol. 47, No. 5. pp. 1061-1066.
@article{72e3f92f6f9c4a1782c50c1321de37f4,
title = "Medical surveillance for antineoplastic-drug handlers",
abstract = "Elements of a medical surveillance program are described, with emphasis on a program for antineoplastic-drug handlers in a hospital setting. There are four data-gathering elements in any medical surveillance program: the history (medical and occupational), the physical examination, laboratory studies, and biological monitoring. Of these, the most useful and cost-effective is the history. The physical examination and laboratory tests should focus on the target organs of the hazardous agent in question. When results of biological monitoring are available for an unexposed control population, results for a group of exposed workers may be interpreted as greater than, similar to, or less than what was expected; thus, groups of unacceptably exposed workers may be identified. For antineoplastic-drug handling, the most important controls are use of a biological-safety cabinet and a worker education program. Estimating the average number of hours of drug handling per shift may serve as a surrogate measure of the potential exposure dose. Health-care professionals examining and testing workers who handle antineoplastic agents should give special emphasis to the skin and the hematopoietic, hepatic, renal, and urinary systems. Because of problems with assay sensitivity, cost, and interpretation of results, biological monitoring is not considered necessary in every medical surveillance program for antineoplastic drug handlers. The Occupational Safety and Health Administration currently recommends that a permanent registry be maintained of all employees who routinely handle antineoplastic agents. Because of their opportunity for exposure to potentially hazardous drugs, pharmacy professionals should take a leading role in establishing surveillance programs that complement existing drug-handling practices and worker education programs.",
keywords = "administration, antineoplastic agents, control, documentation, dosage, education, guidelines, laminar airflow, occupational safety and health administration, personnel, safety, toxicity, environmental",
author = "McDiarmid, {M. A.}",
year = "1990",
language = "English (US)",
volume = "47",
pages = "1061--1066",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "5",

}

TY - JOUR

T1 - Medical surveillance for antineoplastic-drug handlers

AU - McDiarmid, M. A.

PY - 1990

Y1 - 1990

N2 - Elements of a medical surveillance program are described, with emphasis on a program for antineoplastic-drug handlers in a hospital setting. There are four data-gathering elements in any medical surveillance program: the history (medical and occupational), the physical examination, laboratory studies, and biological monitoring. Of these, the most useful and cost-effective is the history. The physical examination and laboratory tests should focus on the target organs of the hazardous agent in question. When results of biological monitoring are available for an unexposed control population, results for a group of exposed workers may be interpreted as greater than, similar to, or less than what was expected; thus, groups of unacceptably exposed workers may be identified. For antineoplastic-drug handling, the most important controls are use of a biological-safety cabinet and a worker education program. Estimating the average number of hours of drug handling per shift may serve as a surrogate measure of the potential exposure dose. Health-care professionals examining and testing workers who handle antineoplastic agents should give special emphasis to the skin and the hematopoietic, hepatic, renal, and urinary systems. Because of problems with assay sensitivity, cost, and interpretation of results, biological monitoring is not considered necessary in every medical surveillance program for antineoplastic drug handlers. The Occupational Safety and Health Administration currently recommends that a permanent registry be maintained of all employees who routinely handle antineoplastic agents. Because of their opportunity for exposure to potentially hazardous drugs, pharmacy professionals should take a leading role in establishing surveillance programs that complement existing drug-handling practices and worker education programs.

AB - Elements of a medical surveillance program are described, with emphasis on a program for antineoplastic-drug handlers in a hospital setting. There are four data-gathering elements in any medical surveillance program: the history (medical and occupational), the physical examination, laboratory studies, and biological monitoring. Of these, the most useful and cost-effective is the history. The physical examination and laboratory tests should focus on the target organs of the hazardous agent in question. When results of biological monitoring are available for an unexposed control population, results for a group of exposed workers may be interpreted as greater than, similar to, or less than what was expected; thus, groups of unacceptably exposed workers may be identified. For antineoplastic-drug handling, the most important controls are use of a biological-safety cabinet and a worker education program. Estimating the average number of hours of drug handling per shift may serve as a surrogate measure of the potential exposure dose. Health-care professionals examining and testing workers who handle antineoplastic agents should give special emphasis to the skin and the hematopoietic, hepatic, renal, and urinary systems. Because of problems with assay sensitivity, cost, and interpretation of results, biological monitoring is not considered necessary in every medical surveillance program for antineoplastic drug handlers. The Occupational Safety and Health Administration currently recommends that a permanent registry be maintained of all employees who routinely handle antineoplastic agents. Because of their opportunity for exposure to potentially hazardous drugs, pharmacy professionals should take a leading role in establishing surveillance programs that complement existing drug-handling practices and worker education programs.

KW - administration

KW - antineoplastic agents

KW - control

KW - documentation

KW - dosage

KW - education

KW - guidelines

KW - laminar airflow

KW - occupational safety and health administration

KW - personnel

KW - safety

KW - toxicity, environmental

UR - http://www.scopus.com/inward/record.url?scp=0025363762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025363762&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 1061

EP - 1066

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 5

ER -